| 時間 | 主題 | ||||
|---|---|---|---|---|---|
PD01-01: Nuclear SUCLG2–EGFR cooperativity drives VEGFA-dependent EGFR-TKI resistance in advanced prostate cancer
講者:
徐志豪
座長:
黃冠華, 虞凱傑 |
徐志豪 |
黃冠華, 虞凱傑 |
|||
PD01-02: Therapeutic Targeting of the MCTP1–FYN–MEF2C Axis Suppresses Neuroendocrine Differentiation and Tumor Progression in Advanced Prostate Cancer
講者:
游家豪
座長:
黃冠華, 虞凱傑 |
游家豪 |
黃冠華, 虞凱傑 |
|||
PD01-03: Staging and Therapeutic Impact of F-18-PSMA-1007 PET Imaging in Newly Diagnosed High-Risk Prostate Cancer
講者:
黃昱凱
座長:
黃冠華, 虞凱傑 |
黃昱凱 |
黃冠華, 虞凱傑 |
|||
PD01-04: Tailoring Salvage Therapy After Prostatectomy: PSMA PET/MR–Guided Comparison of Radiotherapy Alone Versus Radiotherapy Plus ADT
講者:
黃昱凱
座長:
黃冠華, 虞凱傑 |
黃昱凱 |
黃冠華, 虞凱傑 |
|||
PD01-05: Oncologic outcomes following surgical management of contralateral recurrent upper tract urothelial carcinoma: Evidence from a multicenter registry
講者:
李彥良
座長:
黃冠華, 虞凱傑 |
李彥良 |
黃冠華, 虞凱傑 |
|||
PD01-06: Analysis of PSA Superresponders in a Single-Center Study of ¹⁷⁷Lu-PSMA-617 Therapy
講者:
林子翔
座長:
黃冠華, 虞凱傑 |
林子翔 |
黃冠華, 虞凱傑 |